Monday, May 29, 2023
English News
  • Hyderabad
  • Telangana
  • Andhra Pradesh
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Reviews
    • Education Today
    • Property
    • Videos
    • Lifestyle
    • Rewind
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
  • Rewind
Home | India | Pfizer Withdraws Emergency Use Authorisation Application In India

Pfizer withdraws Emergency Use Authorisation application in India

Pfizer will continue to engage with the authority and resubmit its approval request with additional information as it becomes available in the near future.

By PTI
Published Date - 01:04 PM, Fri - 5 February 21
Pfizer withdraws Emergency Use Authorisation application in India
whatsapp facebook twitter telegram

New Delhi: Pharma major Pfizer on Friday said it has decided to withdraw its application for Emergency Use Authorisation (EUA) of its COVID-19 vaccine in India.

Pfizer was the first pharmaceutical firm to seek an emergency use authorisation from the Drugs Controller General of India (DCGI) for its COVID-19 vaccine in the country, after it secured such clearance in the UK and Bahrain.

“In pursuance of the Emergency Use Authorisation of its COVID-19 vaccine, Pfizer participated in the Subject Expert Committee meeting of the Drug Regulatory Authority of India on February 3. Based on the deliberations at the meeting and our understanding of additional information that the regulator may need, the company has decided to withdraw its application at this time,” a company spokesperson said in a statement.

Pfizer will continue to engage with the authority and resubmit its approval request with additional information as it becomes available in the near future, the statement said.

“Pfizer remains committed to making its vaccine available for use by the Government in India and to pursuing the requisite pathway for emergency use authorisation that enables the availability of this vaccine for any future deployment,” the spokesperson said.

Pfizer in its application submitted to the drug regulator in December 2020, had sought permission to import the vaccine for sale and distribution in India, besides waiver of clinical trials on Indian population in accordance with the special provisions under the New Drugs and Clinical Trials Rules, 2019, official sources had said.

  • Follow Us :
  • Tags
  • Covid-19
  • COVID-19 vaccine
  • Emergency Use Authorisation
  • EUA

Related News

  • From honey hunt to thriving business: Journey of a young entrepreneur from Warangal

    From honey hunt to thriving business: Journey of a young entrepreneur from Warangal

  • India records 425 new COVID-19 cases, three fatalities

    India records 425 new COVID-19 cases, three fatalities

  • India logged 490 new COVID-19 cases, two deaths

    India logged 490 new COVID-19 cases, two deaths

  • Here’s why some Covid patients continue to have difficulty in exercising

    Here’s why some Covid patients continue to have difficulty in exercising

  • Health and Tech: Be cautious of avian influenza virus, say experts

    Health and Tech: Be cautious of avian influenza virus, say experts

  • Study finds increased clotting in heart attack patients with Covid-19

    Study finds increased clotting in heart attack patients with Covid-19

Latest News

  • TPDA seeks public cooperation amid shortage of change for Rs 2,000 notes

    2 mins ago
  • Zomato to provide ambulance, medical support to delivery partners

    16 mins ago
  • Mem Famous and 2018 made solid collections in the first weekend of May

    21 mins ago
  • Bengaluru: Four youngsters on weekend trip drown in lake

    29 mins ago
  • Bipasha shares video of her daughter enjoying car ride with Karan Singh Grover

    31 mins ago
  • Twitterati discuss annoying high-beam headlights on city roads

    31 mins ago
  • Update your demographic details in Aadhaar for freeĀ 

    33 mins ago
  • Exercise may lower Parkinson’s disease risk in women by 25%

    51 mins ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam